Updates in Gastrointestinal Oncology – insights from the 2008 44(th )annual meeting of the American Society of Clinical Oncology

por Javle, Milind, Hsueh, Chung-Tsen
Publicado 2009

Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology

por Javle, Milind, Hsueh, Chung-Tsen
Publicado 2010

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma

por Chun, Yun Shin, Javle, Milind
Publicado 2017

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy

por Zuo, Mingxin, Li, Chenglong, Lin, Jiayuh, Javle, Milind
Publicado 2015

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors

por Javle, Milind, King, Gentry, Spencer, Kristen, Borad, Mitesh J
Publicado 2023

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

por Kommalapati, Anuhya, Tella, Sri Harsha, Borad, Mitesh, Javle, Milind, Mahipal, Amit
Publicado 2021

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma

por Pan, Jen-Jung, Javle, Milind, Thinn, Mie Mie, Hsueh, Chung-Tzu, Hsueh, Chung-Tsen
Publicado 2010

Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer

por Javle, Milind, Li, Yanan, Tan, Dongfeng, Dong, Xiaoqun, Chang, Ping, Kar, Siddhartha, Li, Donghui
Publicado 2014

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells

por Lapin, Morten, Tjensvoll, Kjersti, Oltedal, Satu, Javle, Milind, Smaaland, Rune, Gilje, Bjørnar, Nordgård, Oddmund
Publicado 2017

Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with Cancer

por Tennison, Jegy M, Asher, Arash, Hui, David, Javle, Milind, Bassett, Roland L, Bruera, Eduardo
Publicado 2022

Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer

por Roa, Iván, de Toro, Gonzalo, Fernández, Fernanda, Game, Anakaren, Muñoz, Sergio, de Aretxabala, Xabier, Javle, Milind
Publicado 2015

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers

por Connor, Ashton A., Kodali, Sudha, Abdelrahim, Maen, Javle, Milind M., Brombosz, Elizabeth W., Ghobrial, R. Mark
Publicado 2022

Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low C(max) and improved tolerability, in patients with solid tumors

por Ajani, Jaffer A., Javle, Milind, Eng, Cathy, Fogelman, David, Smith, Jackie, Anderson, Barry, Zhang, Chun, Iizuka, Kenzo
Publicado 2020

Reirradiation to the abdomen for gastrointestinal malignancies

por Haque, Waqar, Crane, Christopher H, Krishnan, Sunil, Delclos, Marc E, Javle, Milind, Garrett, Christopher R, Wolff, Robert A, Das, Prajnan
Publicado 2009

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

por Gulhati, Pat, Raghav, Kanwal, Shroff, Rachna, Varadhachary, Gauri, Javle, Milind, Qiao, Wei, Wang, Huamin, Morris, Jeffrey, Wolff, Robert, Overman, Michael J.
Publicado 2017

Adopting Consensus Terms for Testing in Precision Medicine

por Martin, Nikki A., Tepper, Joel E., Giri, Veda N., Stinchcombe, Thomas E., Cheng, Heather H., Javle, Milind M., Konnick, Eric Q.
Publicado 2021

CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

por Agrawal, Shefali, Kuvshinoff, Boris W., Khoury, Thaer, Yu, Jihnhee, Javle, Milind M., LeVea, Charles, Groth, Jeff, Coignet, Lionel J., Gibbs, John F.
Publicado 2007

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

por Abdel-Wahab, Reham, Varadhachary, Gauri R., Bhosale, Priya R., Wang, Xuemei, Fogelman, David R., Shroff, Rachna T., Overman, Michael J., Wolff, Robert A., Javle, Milind
Publicado 2018

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer

por Lapin, Morten, Oltedal, Satu, Tjensvoll, Kjersti, Buhl, Tove, Smaaland, Rune, Garresori, Herish, Javle, Milind, Glenjen, Nils Idar, Abelseth, Bente Kristin, Gilje, Bjørnar, Nordgård, Oddmund
Publicado 2018

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

por Javle, Milind M, Shroff, Rachna T, Xiong, Henry, Varadhachary, Gauri A, Fogelman, David, Reddy, Shrikanth A, Davis, Darren, Zhang, Yujian, Wolff, Robert A, Abbruzzese, James L
Publicado 2010